IRVINE, Calif., May 14, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will host its Annual Meeting of Stockholders on Thursday, May 17, 2018 beginning at 10:00 a.m. PT (1:00 pm ET) at its corporate headquarters in Irvine, California. A live webcast of the […]
Financial
Teleflex Incorporated Hosts Analyst & Investor Day
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, will provide an update on its business and address its 3-year business growth strategy and financial goals during its 2018 Analyst & Investor Day today in New York City. A live webcast of the event presentations will begin […]
BioCardia, Inc. Reports First Quarter 2018 Financial Results And Business Highlights
SAN CARLOS, Calif., May 11, 2018 /PRNewswire/ — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, filed its 10-Q for the three months ended March 31, 2018 with the Securities and Exchange Commission. First Quarter 2018 Financial Results: BioCardia reported a net loss of $3.6 million for the first quarter […]
Vesper Medical Completes $10.5 M Series A Financing to Drive Development of Next Generation Venous Stents
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it completed its Series A financing totaling $10.5 million. Major participants in the Series A financing included New Enterprise Associates and Quaker Partners. The financing occurred in two tranches and is […]
REVA to Hold Annual General Meeting of Stockholders
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its 2018 Annual General Meeting of Stockholders (the “AGM”) on Wednesday, May 16, 2018 at 4:00 p.m. US PDT (which is Thursday, 17 May 2018 at 9:00 a.m. AEST). The meeting will […]
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
VANCOUVER, May 10, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, announced today that it has received written notification (the “Nasdaq Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has […]
Corindus Reports First Quarter 2018 Results
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2018. Recent Highlights and Accomplishments Realized revenue of $1.5 million in the first quarter 2018 Increased CorPath® GRX installed base to 37 systems with […]
Zynex Announces 2018 First Quarter Earnings
ENGLEWOOD, Colo., May 8, 2018 /PRNewswire/ — Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2018. President and CEO […]
Teleflex Announces Quarterly Dividend
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2018 to shareholders of record at the close of business on May 15, 2018. Additional information about […]
BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance
FRANKLIN LAKES, N.J., May 3, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.222 billion for the second fiscal quarter ended March 31, 2018. This represents an increase of 42.2 percent from the prior-year period, which is primarily due to the acquisition […]



